About

Fibrodysplasia ossificans progressiva (FOP) is a severely disabling genetic disorder where soft tissues like muscles and tendons progressively turn into bone, locking joints in place. Garetosmab is an antibody designed to block a key protein called activin A, which normally signals the body to form bone. By interfering with this signal, the drug may slow the abnormal bone formation that gradually restricts movement.